TARRYTOWN, N.Y. — Regeneron Pharmaceuticals Inc. (REGN) on Friday reported fourth-quarter net income of $1.15 billion.
On a per-share basis, the Tarrytown, New York-based company said it had net income of $10.24. Earnings, adjusted for one-time gains and costs, were $9.53 per share.
The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $8.32 per share.
The biopharmaceutical company posted revenue of $2.42 billion in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $2.39 billion.
For the year, the company reported profit of $3.51 billion, or $30.52 per share. Revenue was reported as $8.5 billion.
Regeneron shares have risen slightly more than 3% since the beginning of the year, while the Standard & Poor's 500 index has risen 3%. The stock has risen 40% in the last 12 months.
ASTORIA – Variety Boys & Girls Club of Queens was recently selected a winner in Round Three of New York State’s Buildings of Excellence Competition for the design and construction of a low-carbon (or net-zero) emitting multifamily building.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.07 USD
